FRAMINGHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder, Interim CEO, and Executive Chairman, Jason Krantz, will present at the J.P. Morgan Global Technology, Media and Communications Conference.
Definitive Healthcare Corp. (NASDAQ:DH ) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Matthew Ruderman - Investor Relations Jason Krantz - Founder, Executive Chairman and Interim Chief Executive Officer Rick Booth - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Jared Haase - William Blair Matt Shea - Needham & Company Anne...
FRAMINGHAM, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its first quarter ended March 31, 2024, on Tuesday, May 7, 2024 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 ...
Partnership offers solution to streamline engagement between pharmaceutical companies and KOLs to help increase the value of the clinical collaborations and conversations Partnership offers solution to streamline engagement between pharmaceutical companies and KOLs to help increase the value of the clinical collaborations and conversations
Definitive Healthcare stock is recommended as a buy due to strong long-term growth prospects and potential for margin expansion. Recent results show revenue growth in line with estimates and improved profitability, despite concerns about net dollar retention and customer churn. Management guidance supports a turnaround in FY25, with indicators of healthy organic demand and potential for growth ...
FRAMINGHAM, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH ), an industry leader in healthcare commercial intelligence, today announced that it has been named one of the Boston Business Journal's Middle Market Leaders for 2024, a ranking of the 50 highest growth companies in Massachusetts. This marks the second year in a row that Definitive Healthcare has won this...
Fourth quarter revenue grew 9% year-over-year to $65.9 million Full year 2023 revenue grew 13% year-over-year to $251.4 million FRAMINGHAM, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter and full year ended De...
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.